Healthcare provider profile · identity verified

Saif U Bajwa, MD

Internal Medicine · LAKE ELSINORE, CA · NPI 1043390040

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	631	193
Lisinopril	Lisinopril	468	141
Gabapentin	Gabapentin	374	124
Levothyroxine Sodium	Levothyroxine Sodium	369	99
Amlodipine Besylate	Amlodipine Besylate	337	107
Metoprolol Succinate	Metoprolol Succinate	250	74
Pantoprazole Sodium	Pantoprazole Sodium	230	73
Albuterol Sulfate Hfa	Albuterol Sulfate	220	54
Losartan Potassium	Losartan Potassium	217	63
Metformin Hcl	Metformin Hcl	193	62
Metoprolol Tartrate	Metoprolol Tartrate	193	57
Omeprazole	Omeprazole	187	60
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	29
Famotidine	Famotidine	176	51
Tamsulosin Hcl	Tamsulosin Hcl	162	52
Prednisone	Prednisone	136	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	134	28
Ibuprofen	Ibuprofen	128	37
Duloxetine Hcl	Duloxetine Hcl	124	41
Glipizide Er	Glipizide	120	38
Glipizide	Glipizide	118	35
Hydrochlorothiazide	Hydrochlorothiazide	116	35
Hydrocortisone	Hydrocortisone	113	50
Furosemide	Furosemide	105	39
Ozempic	Semaglutide	105	21
Eliquis	Apixaban	103	22
Benazepril Hcl	Benazepril Hcl	99	28
Hydralazine Hcl	Hydralazine Hcl	94	31
Fluticasone Propionate	Fluticasone Propionate	89	31
Azithromycin	Azithromycin	84	58
Lorazepam	Lorazepam	79	13
Simvastatin	Simvastatin	75	26
Tramadol Hcl	Tramadol Hcl	74	20
Atenolol	Atenolol	73	18
Buspirone Hcl	Buspirone Hcl	72	28
Sertraline Hcl	Sertraline Hcl	67	18
Lantus	Insulin Glargine,hum.Rec.Anlog	66	12
Trazodone Hcl	Trazodone Hcl	66	17
Carvedilol	Carvedilol	64	17
Clopidogrel	Clopidogrel Bisulfate	61	23
Triamcinolone Acetonide	Triamcinolone Acetonide	61	23
Levofloxacin	Levofloxacin	55	32
Ondansetron Odt	Ondansetron	54	28
Baclofen	Baclofen	48	14
Acetaminophen-Codeine	Acetaminophen With Codeine	47	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	14
Diclofenac Sodium	Diclofenac Sodium	45	28
Potassium Chloride	Potassium Chloride	44	16
Alcohol Prep Pads	Alcohol Antiseptic Pads	43	17
Raloxifene Hcl	Raloxifene Hcl	43	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Finasteride	Finasteride	38	12
Rosuvastatin Calcium	Rosuvastatin Calcium	37	11
Ventolin Hfa	Albuterol Sulfate	37	13
Alendronate Sodium	Alendronate Sodium	35	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Brilinta	Ticagrelor	32	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	32	12
Hydroxyzine Hcl	Hydroxyzine Hcl	32	16
Januvia	Sitagliptin Phosphate	32	12
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	11
Humalog Kwikpen U-100	Insulin Lispro	26	12
Lidocaine	Lidocaine	26	suppressed
Nystatin	Nystatin	26	12
Allopurinol	Allopurinol	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	23	11
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Linzess	Linaclotide	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Cephalexin	Cephalexin	21	15
Lovastatin	Lovastatin	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	13
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Amoxicillin	Amoxicillin	16	12
Donepezil Hcl	Donepezil Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Nyamyc	Nystatin	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Promethazine-Dm	Promethazine/Dextromethorphan	14	suppressed
Clonidine	Clonidine	13	suppressed
Comfort Ez Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Topamax	Topiramate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Comfort Ez Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error